April 2020: an ambulance picks up a possible covid patient near Liège. Whether the pill really makes a difference – and thus reduces the risk of hospitalization – will be known in September or October. — © afp
The drug company Merck is investigating whether molnupiravir can prevent the first symptoms from derailing into severe covid-19. It is one of the few drugs in the pipeline to avoid hospital admissions.
Read Also
- 10% of the population vaccinated by September Jun 3, 2021
- La Plata: They deliver ballots from the Frente de Todos with bibs from the Ministry of Health and the vaccination campaign Aug 28, 2021
- A critical analysis of the therapeutic protocol of the Pr Raoult Jul 1, 2020
- Doctors had to change procedure during the Pope’s operation Jul 9, 2021
- Paro Fenats: 61 surgeries have been suspended at the Regional Hospital of Concepción in 3 days Nov 11, 2022
- What is ‘black fungus’ affecting covid-19 patients in India? May 31, 2021
- Mental health: At the Maison Perchée, young people suffering from bipolarity and schizophrenia help each other Nov 19, 2022
Maxie Eckert
Today at 11:34 AM
.
